WDFY3 and Parkinson disease: Deficits or pathogenic mutations in BEACH-containing proteins other than WDFY3 in humans (Fig. 2B) are associated with bipolar disorder, schizophrenia, epilepsy, ASD, and neurodegenerative diseases, such as AD, ALS and Parkinson’s disease (Fig. 2B).